Skip to main content

Table 2 Tolerability of a ramped, moderate-to-vigorous intensity, exercise prescription with weekly tele-coaching

From: Feasibility of a tailored home-based exercise intervention during neoadjuvant chemotherapy in breast cancer patients

 

Exercise time (min/wk)

Average HR during exercise (bpm)

Average HR prescribed (bpm)

Exercise time at Rx HR (%)

Introduction phase

64.2 ± 6.8

134.2 ± 9.5

122.7 ± 13.3

72.7 ± 11.5

Intermediate phase

67.1 ± 5.7

139.3 ± 3.5

141.9 ± 12.3

61.0 ± 5.0

Maintenance phase

66.0 ± 10.4

137.8 ± 7.3

149.0 ± 11.5

23.7 ± 7.1

  1. Mean ± SEM for patients that progressed at least 2 weeks into the introduction phase (n = 6)